Curis (CRIS) Other Operating Expenses (2012 - 2025)
Curis' (CRIS) quarterly Other Operating Expenses came in at $15000.0 in Q3 2025, down 31.82% YoY from $22000.0 in Q3 2024, and down 6.25% on a QoQ basis from $16000.0 in Q2 2025.
Curis (CRIS) Other Operating Expenses (2012 - 2025) Analysis & Trends
Curis (CRIS) has 14 years of Other Operating Expenses data on file, last reported at $15000.0 in Q3 2025.
- Quarterly Other Operating Expenses fell 31.82% year-over-year to $15000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $31000.0 (down 52.31% YoY) and the FY2025 annual result came in at $27.2 million, changed N/A from the prior year.
- Other Operating Expenses slipped to $15000.0 in Q3 2025, from $16000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $157000.0 in Q4 2021 to a low of $12000.0 in Q2 2024.
- A 5-year average of $60263.2 and a median of $54000.0 in 2023 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 95.83% in 2024, down 83.78% in 2024.
- Tracing CRIS's Other Operating Expenses over 5 years: stood at $157000.0 in 2021, then plunged by 54.78% to $71000.0 in 2022, then decreased by 23.94% to $54000.0 in 2023, then tumbled by 68.52% to $17000.0 in 2024, then dropped by 11.76% to $15000.0 in 2025.
- The last three Other Operating Expenses figures came in at $15000.0 (Q3 2025), $16000.0 (Q2 2025), and $14000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 74,000.00 |
| Mar 31, 2023 | 24,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 62,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Mar 31, 2021 | 109,000.00 |
| Dec 31, 2020 | 152,000.00 |